0001582554 EX-FILING FEES 0001582554 2025-06-23 2025-06-23 0001582554 1 2025-06-23 2025-06-23 0001582554 2 2025-06-23 2025-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

Matinas BioPharma Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type
  Security
Class Title
  Fee
Calculation
Rule
  Amount Registered (1)   Proposed
Maximum
Offering
Price
Per Unit 
   Maximum
Aggregate Offering
Price
   Fee Rate   Amount of
Registration
Fee
 
Equity   Common Stock, $0.0001 par value per share   Other     116,500 (2)       $0.59 (3)      $ 68,735.00 (3)       0.00015310     $ 10.53  
Equity  Common Stock, $0.0001 par value per share  Other   646,548 (4)  $0.9085 (5)  $587,388.86 (5)   0.00015310   $89.93 
Total Offering Amounts       $656,123.86       $100.46 
Total Fee Offsets                 
Net Fees Due               $100.46 

 

(1)  Covers 763,048 shares of common stock issuable under the Matinas BioPharma Holdings, Inc. 2025 Equity Incentive Plan (the “2025 Plan”). In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plan(s) described herein, as these amounts may be adjusted as a result of stock splits, stock dividends, antidilution provisions, and similar transactions.
(2) Consists of shares of common stock that may be issued upon exercise of stock options granted pursuant to the 2025 Plan (the “Stock Options”) outstanding as of the date of this registration statement.
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) promulgated under the Securities Act. The offering price per share and the aggregate offering price for shares issuable upon the exercise of the Stock Options are based upon the weighted average exercise price of the Stock Options.
(4) Represents shares of common stock reserved for future issuance under the 2025 Plan that are not subject to outstanding options.
(5) Calculated solely for purposes of this offering under Rules 457(c) and 457(h) of the Securities Act on the basis of the average of the high and low prices of Registrant’s common stock on the NYSE American on June 20, 2025.